Health

Regulation Needs to Keep Pace With Global Cannabis Legalisation in 2019 - Prohibition Partners

LONDON, Aug. 22, 2019 /PRNewswire/ -- The number of countries to legalise medical cannabis has risen nine-fold in the last five years, as global attitudes towards cannabis have shifted in favour of liberalisation. In 2019, 43 countries have legalised medical cannabis, with a host more allowing p...

2019-08-22 19:54 143

Luye Pharma's Investigational Drug Ansofaxine Hydrochloride Extended Release Tablets to Start Clinical Trials in Japan

TOKYO, Aug. 22, 2019 /PRNewswire/ -- Luye Pharma Group has announced its submission of the clinical trials application for a new chemical drug, Ansofaxine Hydrochloride Extended Release Tablets (LY03005) for the treatment of depression inJapan, with the trials expected to begin soon. Meanwhile, p...

2019-08-22 15:36 190

The CareVoice Closes Eight Figure USD Series A Funding Round

SHANGHAI, Aug. 22, 2019 /PRNewswire/ -- The CareVoice, an international health insurtech company based inChina, announced today that it has successfully raised an eight-figure USD Series A funding round. The round was led by a global investment group, LUN Partners Group, and a global investment m...

2019-08-22 12:48 304

Tahir Foundation launches new partnership to end malaria in Indonesia

JAKARTA, Indonesia, Aug. 22, 2019 /PRNewswire/ -- In a joint partnership, the Tahir Foundation and the Asia Pacific Leaders Malaria Alliance (APLMA)[1]  announced the launch of M2030 inIndonesia. Started by APLMA in 2018, M2030[2] is a movement that brings together businesses, consumers and healt...

2019-08-22 08:00 309

Innovent Enters a Licensing Agreement with Lilly to Develop & Commercialize a Novel Diabetes Medicine in China

SUZHOU, China, Aug. 22, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines, today announced that it has entered into a licensing agreement with Eli Lilly and Company (Lilly) for th...

2019-08-22 07:30 310

Super Antioxidant Ergothioneine Achieves GRAS Status from FDA

Decision Drives Anti-Aging Market Emerging Studies Reveal Ergothioneine consumption is Correlated to Reducing Mild Cognitive Impairment RANCHO SANTA MARGARITA, California, Aug. 22, 2019 /PRNewswire/ -- Southern California-based ingredient supplier and manufacturer, Blue California announced th...

2019-08-22 04:50 330

Pneuma Respiratory, Inc. Announces New Chairman of the Board

BOONE, North Carolina, Aug. 22, 2019 /PRNewswire/ -- Pneuma Respiratory, Inc. announced that Board memberJay Morgan has assumed the position of Chairman of the Board. Pneuma's previous Chairman,Walt Robb, will remain a member of the Board of Directors. Jay Morgan served as VP Global Innovation a...

2019-08-22 03:17 341

Biotech Conagen Acquires Production Platform of Therapeutic Proteins

The technology should reduce costs to patients and accelerate drug development   BEDFORD, Massachusetts, Aug. 22, 2019 /PRNewswire/ -- Conagen, a vertically integrated synthetic biology company located inBoston's biotech corridor, announced today that it has acquired a fermentation-based technolo...

2019-08-22 01:39 360

CMAB and Kintor Announce a New Comprehensive Collaboration to Develop and Manufacture the ALK-1 Monoclonal Antibody

* This agreement represents the first strategic cooperation between two of the key players in biopharmaceutical industries in Suzhou,China * ALK-1 (Activin receptor-like kinase-1) antibody was originally developed by Pfizer who completed two Phase I clinical trials in more than 100 patients wi...

2019-08-21 21:35 952

Global Cord Blood Corporation to Report First Quarter Fiscal 2020 Financial Results

HONG KONG, Aug. 21, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company") today announced that it plans to release financial results for the first quarter fiscal 2020 onTuesday, August 27, 2019, after the market close.  The Company will host a conference call at 8:00 a.m....

2019-08-21 19:00 1221

NeuroVive Pharmaceutical AB Interim Report January - June 2019

STOCKHOLM, Aug. 21, 2019 /PRNewswire/ -- Important events April - June * The US Food and Drug Administration, FDA, approves NeuroVive's IND (Investigational New Drug) application, enabling clinical studies in the US with the company's drug candidate NeuroSTAT. * The Supreme Court delivers it...

2019-08-21 15:24 1350

Joway Health Industries Group Inc. Responds To Promotional Publications

TIANJIN, China, Aug. 21, 2019 /PRNewswire/ -- On August 16, 2019, Joway Health Industries Group Inc. (the "Company") received an inquiry from the OTC Markets concerning the recent publication of three separate statements published on the websites of certain stock promoters, with a resultant rise ...

2019-08-21 13:20 363

Isagenix Names Global IsaBody Challenge Grand Prize Winner

Thomas Philbin-Malucelli of Sydney, Australia, Takes Home US$50,000 in Worldwide Health and Wellness Competition GILBERT, Arizona, Aug. 21, 2019 /PRNewswire/ -- Isagenix International, a global health and wellness company providing nutrition and lifestyle solutions, has announced aSydney, Austral...

2019-08-21 08:00 423

Clinical Decision Support Systems Revolutionize the EMR to Become the Leader for Patient Empowerment

SANTA CLARA, California, Aug. 20, 2019 /PRNewswire/ -- Clinical decision support systems (CDSS) are poised to become the user interface of choice for clinical interactions with health IT, ultimately supplanting theelectronic health record (EHR) system as the primary health IT point of interface f...

2019-08-20 22:36 517

NCCN Updates Spanish Adaptations of NCCN Guidelines to Enable Better Cancer Prevention, Diagnosis, and Treatment in Spain

New and improved mobile app and upcoming NCCN Global Academy event reflect the organization's efforts to increase worldwide access to NCCN resources. #NCCNGlobal PLYMOUTH MEETING, Pennsylvania, Aug. 20, 2019 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®) has begun publishing u...

2019-08-20 19:35 502

CStone submits an abstract on CS1001-201 trial to 2019 ASH Annual Meeting

SUZHOU, China, Aug. 20, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616) today announced that an abstract on the company's CS1001-201 trial has been submitted to the upcoming 2019 American Society of Hematology (ASH) Annual Meeting. This will mark the first release of CS1001-201...

2019-08-20 10:18 2351

WuXi Biologics Reports Outstanding Interim Results

* 52.4% Year-on-Year Revenue Growth to RMB1,607.1 Million * Net Profit Increased 80.1% Year-on-Year to RMB449.5 Million * Gross Profit Margin, Net Profit Margin and Adjusted Net Profit Margin All Record High * Total Backlog Surged to US$4.6 Billion * 32 New Integrated Projects Including 1...

2019-08-19 22:09 2890

China SXT Pharmaceuticals, Inc. Announces Filing of Annual Report on Form 20-F for Year Ended March 31, 2019

TAIZHOU, China, Aug. 19, 2019 /PR Newswire/ -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces ("TCMPs"), today annou...

2019-08-19 20:00 2911

Merck Granted Seven Additional CRISPR Patents, Bringing Total to 20 Worldwide

DARMSTADT, Germany, Aug. 19, 2019 /PRNewswire/ -- Merck, a leading science and technology company, today announced that the European, Israeli, South Korean and U.K. intellectual property offices have issued formal notices allowing seven additional Merck patent application claims covering CRISPR g...

2019-08-19 20:00 731

WuXi AppTec Reports First Half 2019 Interim Results

* Revenue Accelerated 33.7% Year-Over-Year to RMB 5,894 Million * Gross Profit Up 30.0% Year-Over-Year to RMB 2,284 million[1] * Adjusted Non-IFRS Net Profit Attributable to Owners of the Company Up 32.0% Year-Over-Year toRMB 1,179 Million * Small Molecule CDMO/CMO Pipeline has Grown to 800...

2019-08-19 19:20 713
12345 ... 746